PROSCA 2018

The Global Congress on Prostate Cancer brings together top experts and delegates from several disciplines, for an in-depth discussion of the different aspects of prostate cancer, with a focus on difficulties and dilemmas of clinical decision making, settled in an inspiring location.

Comparative analysis of PSA kinetics related to 4 different radiotherapy modalities

Acosta Rojas

Angel

University Hospitals HM Sanchinarro & HM Puerta del Sur

Madrid

Spain

View abstract

Metachronous malignant brain tumor in patient with metastatic prostate cancer : a case report

Ait Erraisse

Mohamed

University hospital Hassan II

Fez

Morocco

View abstract

Prostate cancer : a single-institution experience

Ait Erraisse

Mohamed

University hospital Hassan II

Fez

Morocco

View abstract

Multiple lines of treatment improve OS in Castrate resistant prostate cancer

Akhtar

Mateen

Colchester General Hospital

Colchester

Essex

View abstract

The thyroid hormone/µ-crystalline axis is a key player in prostate cancer growth and a novel marker for prostate cancer progression in men

Aksoy

Osman

Medical university of Vienna

Vienna

Austria

View abstract

68Ga-PSMA PET/CT IN PATIENTS WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: HOW TO PREDICT A POSITIVE PSMA PET/CT RESULTS AND THE SITE OF RECURRENCE.

Angiolini

Andrea

S.Orsola-Malpighi University Hospital

Bologna

Italy

View abstract

Predicting bone metastasis on pretreatment imaging in men with intermediate or high risk prostate cancer: a nationwide, population-based study

Arnsrud Godtman

Rebecka

Sahlgrenska University Hospital

Göteborg

Sverige

View abstract

A prospective study of Carcinoma Prostate patients at a tertiary institute in North India with special emphasis on their bone health

Bhaskar

Ved

Medanta

Gurgaon

India

View abstract

68Ga-PSMA PET/CT IN BIOCHEMICAL RECURRENCE AFTER A RADICAL TREATMENT FOR PROSTATE CANCER: DETECTION RATE AND COMPARISON WITH CONVENTIONAL IMAGING AND CHOLINE PET/CT

Bianchi

Lorenzo

S.Orsola-Malpighi University Hospital

Bologna

Italy

View abstract

CLINICAL IMPACT OF 68Ga-PSMA PET/CT ON THE MANAGEMENT OF PATIENTS EXPERIENCING BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY

Bianchi

Lorenzo

S.Orsola-Malpighi University Hospital

Bologna

Italy

View abstract

Characterizing Rectal Dosimetry In Patients Who Have Received Definitive SBRT for Prostate Cancer: The 7-year Freedom From Proctitis In A Large Patient Cohort

Blacksburg, M.D.

Seth

NYU Winthrop Hospital

New York

USA

View abstract

Grade 2+ Bladder Toxicity in Patients Receiving SBRT for Prostate Cancer: Incidence and Dosimetric Characterization In A Large Patient Cohort

Blacksburg, M.D.

Seth

NYU Winthrop Hospital

New York

USA

View abstract

PSA Nadir 2 Years After Definitive SBRT for Prostate Cancer: Predictors of Absolute PSA Decline

Blacksburg, M.D.

Seth

NYU Winthrop Hospital

New York

USA

View abstract

Regulatory functions of SOCS1 in the Prostate gland

Bobbala

Diwakar

Centre hospitalier universitaire de Sherbrooke |(CHUS)

Sherbrooke

Canada

View abstract

Exercise training as a novel primary treatment for low and intermediate risk localised prostate cancer: a multi-site randomised controlled phase II study

Bourke

Liam

Royal Hallamshire Hospital (honorary staff)

Sheffield

View abstract

Does nerve sparing radical prostatectomy increase the rate of positive surgical margin?

Britto

Maneka

Alfred Hospital

MELBOURNE

Australia

View abstract

Pragmatic prognostic model to guide early management of patients with newly diagnosed metastatic prostate cancer

Buelens

Sarah

University Hospital Ghent

Ghent

Belgium

View abstract

Long-term follow-up of a single-center experience of radiotherapy after prostatectomy in prostate cancer patients. (1993-2008).

Casas

Francesc

Hospital Clínic

Barcelona

Spain

View abstract

High dose rate Brachytherapy as Monotherapy for Localised Prostate Cancer: Early outcomes

Challapalli

Amarnath

Bristol Cancer Institute

Bristol

United Kingdom

View abstract

Outcomes of Upfront Docetaxel with Hormone Therapy in elderly patients with metastatic hormone-naïve prostate cancer.

Challapalli

Amarnath

Bristol Cancer Institute

Bristol

United Kingdom

View abstract

Predictive value of 68Ga-PSMA PET and mpMRI for the presence of clinically significant prostate cancers on histopathology. Does 68Ga-PSMA PET add value to mpMRI?

Chang

John

Garvan Institute

Sydney

Australia

View abstract

Feasibility of spacer insertion for dose-escalated post-prostatectomy radiotherapy (PPRT) and the impact on rectal dosimetry

Chao

Michael

Genesiscare

Melbourne

Australia

View abstract

HDR brachytherapy: Can the urologist help reduce urinary and bowel toxicity?

Chao

Michael

GenesisCare

Melbourne

Australia

View abstract

Space Matters - Increased Spacing using Balloon Leads to Superior Outcomes in Prostate Radiotherapy

Costa

Paulo

CUF Porto Hospital

Porto

Portugal

View abstract

Stereotactic body radiotherapy for nodal oligorecurrent prostate cancer: a multi-institutional analysis

De Bleser

Elise

University Hospital Ghent

Ghent

Belgium

View abstract

Nodal oligorecurrent prostate cancer: anatomical pattern of relapse in relation to elective surgical and radiotherapy treatment templates.

De Bruycker

Aurélie

Ghent University Hospital

Ghent

Belgium

View abstract

Ethnic Paradigm in Prostate Cancer - Does it really matter?

De Olveira E Silva

Tania

CHU Saint Pierre

Brussels

Belgium

View abstract

Correlation of radiological signs in multiparametric magnetic resonance imaging and pathological characteristics in prostate cancer.

Durá Esteve

Jorge

12 de Octubre University Hospital

Madrid

Spain

View abstract

Age, Race and Family History relationship with Prostate Cancer. Our experience.

Falcao

Gil

Centro Hospitalar Lisboa Central

Lisbon

Portugal

View abstract

Contribution of multiparametric magnetic resonance imaging in the diagnosis, staging and treatment of prostate cancer.

Fernández Alonso

Sandra

12 de Octubre University Hospital

Madrid

Spain

View abstract

Late toxicity in pelvic intensity modulated arc therapy (IMAT) for locally advanced prostate cancer

Ferrer

Ferran

Catalan Institute of Oncology

L'Hospitalet- Barcelona

Spain

View abstract

ONCOLOGIC RESULTS ASSOCIATED WITH COMBINED PTEN LOSS AND ERG EXPRESSION IN PROSTATE CANCER PATIENTS AFTER RADICAL PROSTATECTOMY.

Fragkoulis

Charalampos

General Hospital of Athens G.N.A. G. Gennimatas

Athens

Greece

View abstract

DISAPPEARANCE OF CHRONIC PELVIC PAIN SYMPTOMS AFTER LAPAROSCOPIC RADICAL PROSTATECTOMY IN A PATIENT WITH A PROSTATE CARCINOMA AND CHRONIC PELVIC PAIN SYNDROME.

Garcia-Rojo

Dario

Hospital Sabadell

Sabadell

Spain

View abstract

Expression of SOCS1 and mediators of its tumor suppressor functions in prostate cancer specimens

ILANGUMARAN

Subburaj

Centre hospitalier universitaire de Sherbrooke

Sherbrooke

Canada

View abstract

Use of Docetaxel plus Androgen-Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer in Korean Patients

Joung

Jae Young

National Cancer Center

Goyang

Republic of Korea

View abstract

Microsatellite AR and VDR markers as genetic risk factors in association with Prostate cancer

Kavrakova

Anita

Genetic Medico-Diagnostic Laboratory “Genica”

Sofia

Bulgaria

View abstract

The clinical significance of the number of positive cores of chronic inflammation in prostate needle biopsy specimen.

Kim

Taek Sang

Kosin University Gospel Hospital

Busan

Korea, South

View abstract

The cumulative incidence and risk factor of postoperative inguinal hernia in patient undergone radical prostatectomy

Ja Yoon

Pusan National University Hospital

Busan,

South Korea

View abstract

Elevated Ki-67 (MIB-1) expression as an independent predictor for unfavorable pathologic outcomes and biochemical recurrence after radical prostatectomy in patients with localized prostate cancer: a propensity score matched study.

Lee

Hakmin

Seoul National University Bundang Hospital

Seong-Nam

South Korea

View abstract

Evaluation of prostate cancer stage groups updated in the eighth edition of the American Joint Committee on Cancer tumor-node-metastasis Staging Manual

Lee

Hakmin

Seoul National University Bundang Hospital

Seong-Nam

South Korea

View abstract

The Correlation Between abdominal obesity and prostate cancer in Korea

LEE

JEA WHAN

Wonkwang University School of Medicine

IKSAN

Korea

View abstract

Pathological characteristics of prostate cancer in younger men

Macneil

James

Orange Health Service

Orange

Australia

View abstract

Upgrading from Biopsy to Radical Prostatectomy in Low Risk Prostate Cancer Patients. Appliying Real World Evidence for Adecuations of Guidelines in a Single Center Based on its Own Experience.

Manduley

Alejandro

Complejo Hospitalario Metropolitano

panama

Panamá

View abstract

Adverse Pathologic Features for Patients with Metastatic Prostate Cancer treated with Cytoreductive Radical Prostatectomy: Results of a Single-institution Series

Mao

Shiyu

Shanghai Tenth People’s Hospital

Shanghai

China

View abstract

Effect of cytoreductive radical prostatectomy on levels of circulating tumor cells of patients with metastatic prostate cancer

Mao

Shiyu

Shanghai Tenth People’s Hospital

Shanghai

China

View abstract

EARLY SALVAGE RADIOTHERAPY FOR PATIENTS TREATED WITH RADICAL PROSTATECTOMY AND ADVERSE PATHOLOGIC FEATURES: PRELIMINARY RESULTS FROM “EASY-1 (EArly Salvage RadiotherapY-1) PROTOCOL”

Mineo Bianchi

Federico

S.Orsola-Malpighi University Hospital

Bologna

Italy

View abstract

Identification of long non-coding RNAs (lncRNAs) involved in chromosomal instability in a model of prostate cancer

Montiel Manriquez

Rogelio

National Cancer Institute of Mexico

Mexico City

Mexico

View abstract

IMPACT OF SARCOPENIA ON THE GLOBAL SURVIVAL OF PATIENTS WITH PROSTATE CANCER WITH METASTATIC DEBUT TREATED WITH ANDROGENIC-DEPRIVATION THERAPY

Muñoz-Rodriguez

Jesus

Hospital Universitari Parc Tauli

Sabadell

Spain

View abstract

ANALYSIS OF THE COST OF THE USE OF THE PCA3 IN PATIENTS WITH INDICATION OF SECOND PROSTATE BIOPSIES

Murgui Rodriguez

María

Hospital San Pedro de Alcántara

Cáceres

Spain

View abstract

Risk of prostate cancer diagnosis and prostate cancer death after a negative biopsy for men participating in a screening trial

Palmstedt

Emmeli

Sahlgrenska University Hospital

Gothenburg

Sweden

View abstract

The effectiveness of biparametric MRI-ultrasound fusion prostate biopsy on detecting the clinically significant prostate cancer.

Park

Kyung kgi

Jeju National University

Jeju

South Korea

View abstract

The difference of AR variants expression in 2D and 3D culture of castration resistant prostate cancer cell under curcumin

Park

Sung Woo

Pusan National University Yangsan Hospital

Yangsan

South Korea

View abstract

The Expression of Androgen Receptor and Its Variants in Human Prostate Cancer Tissue according to disease status

Park

Sung Woo

Pusan National University Yangsan Hospital

Yangsan

South Korea

View abstract

[18F]PSMA-HBED For PET Imaging Of Prostate Cancer: First-In-Human Results

Piron

Sarah

Ghent University

Ghent

Belgium

View abstract

Formation and abilities of stromal cells in cultures of human prostate tissue

Popov

Boris

Institute of Cytology Russian Academy of Sciences

St.Petersburg

Россия

View abstract

Does Gleason Score 3+3 on the radical prostatectomy specimen mean that the patient is cured?

Ragnebäck Hammer

Pia

Sahlgrenska University Hospital

Gothenburg

Sweden

View abstract

Home-based palliative care for advanced prostate cancer patients in a resource-poor setting (Ghana): A Multiple perspective, multi-method study

Salifu

Yakubu

Queen's Medical Centre, Nottingham

Nottingham

United Kingdom

View abstract

Population-based study of grade progression in patients who harboured Gleason 3 + 3

Sampurno

Fanny

Monash University

Melbourne

Australia

View abstract

Regional Differences in the Treatment of Localized Prostate Cancer in the United States

Scherzer

Nickolas

Tulane University School of Medicine

New Orleans

United States of America

View abstract

THE ROLE OF MAGNETIC RESONANCE IMAGING FOR EARLY RECLASSIFICATION OF PATIENTS UNDERGOING ACTIVE SURVEILLANCE FOR PROSTATE CANCER (ROMAS PROJECT): A MULTI-INSTITUTIONAL PRELIMINARY EXPERIENCE

Schiavina

Riccardo

S. Orsola-Malpighi University Hospital

Bologna

Italy

View abstract

SelectMDx Impacts Prostate Biopsy Decision-making in Routine Clinical Practice

Shore

Neal

Carolina Urologic Research Center

Myrtle Beach, SC

USA

View abstract

Positive surgical margins after radical prostatectomy in obese patients: retropubic vs robotic-assisted vs perineal approach

Sokolov

Yegor

S.P. Botkin's State Clinical Hospital; Russian Medical Academy of Continuous Professional Education

Moscow

Russia

View abstract

Oncological outcomes of irreversible electroporation (Nanoknife) for localised clinically significant prostate cancer at single Australian centre.

Stricker

Phillip

St. Vincent's Hospital, Sydney

Sydney

Australia

View abstract

Androgen receptor phosphorylation at serine residue 578 predicts poor outcome in hormone-naïve prostate cancer patients

Taylor

Bruce

University of Glasgow

Glasgow

Scotland

View abstract

Robust performance of a urinary molecular biomarker–based risk score to detect high-grade prostate cancer using optimised cascading models

Trooskens

Geert

Ghent University

Ghent

Belgium

View abstract

Assessment of a urinary TRUS/biomarker-based risk score as inclusion criteria for multiparametric MRI to detect clinically significant prostate cancer

Trooskens

Geert

MDxHealth

Irvine, CA

USA

View abstract

A qualitative evaluation of exercise training as a novel primary therapy for men with low and intermediate risk Prostate cancer.

Turner

Rebecca

Royal Hallamshire Hospital

Sheffield

England

View abstract

177u-PSMA-617 radioligand therapy for lymph node-positive prostate cancer

von Eyben

Finn

Center for Tobacco Control Research

Odense

Denmark

View abstract

Second series of cycles of 177Lu-PSMA-617 radioligand therapy for patients with lymph node metastatic prostate cancer. A report of two cases

von Eyben

Finn

Center for Tobacco Control Research

Odense

Danmark

View abstract

Detection rate of MRI fusion ultrasound prostate biopsy with transrectal and transperineal approach

Woranisarakul

Varat

Siriraj

Bangkok

Thailand

View abstract